• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

C.R. Bard

N.J. appeals court tosses $83M pelvic mesh verdicts against J&J, Bard

March 3, 2021 By Nancy Crotti

A New Jersey appeals court yesterday threw out jury verdicts totaling $83 million in separate pelvic mesh lawsuits against Johnson & Johnson’s  (NYSE:JNJ) Ethicon division and Becton Dickinson (NYSE:BDX) subsidiary C.R. Bard. In both cases, Bergen County, N.J. judges erred by disallowing evidence showing that each company’s mesh product had received FDA 510 (k) clearance, according […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Legal News, Product Liability, Regulatory/Compliance, Women's Health Tagged With: AdvaMed, becton dickinson, C.R. Bard, Ethicon, Johnson & Johnson, pelvic mesh

Bard prevails in pelvic mesh trial

October 15, 2020 By Sean Whooley

The Supreme Court of Missouri ruled in favor of Becton Dickinson’s (NYSE:BDX) C.R. Bard business in a lawsuit alleging liability issues with its pelvic mesh. In 2013, Eve Sherrer filed claims over polypropylene mesh slings that she’d had implanted in 2011 and 2012 to treat urinary incontinence, including claims for negligence, design and manufacturing defects, and […]

Filed Under: Featured, Gynecological, Legal News, Women's Health Tagged With: becton dickinson, Boston Scientific, C.R. Bard

AdvaMed launches campaign against ‘misleading’ legal advertising

September 25, 2020 By Nancy Crotti

Medtech trade group AdvaMed this week debuted a website that tracks law firm TV advertisements aimed at patients who have had certain medical devices implanted. The “Responsible Advertising for Patient Safety” site says that such ads mislead patients into legal action against the manufacturers of devices that are “non-faulty” and may jeopardize patient safety. Get the full […]

Filed Under: Business/Financial News, Featured, Implants, Legal News Tagged With: AdvaMed, becton dickinson, Boston Scientific, C.R. Bard

BD is paying $60M to settle Bard pelvic mesh suits with most U.S. states

September 24, 2020 By Chris Newmarker

Becton Dickinson (NYSE:BDX) will pay $60 million to 48 U.S. states to resolve allegations that its C.R. Bard business deceptively marketed transvaginal surgical mesh devices, state attorneys general in California and Washington announced today. Mesh products were meant to treat the weakening of the muscles and ligaments supporting a woman’s pelvic organs, but they instead sparked […]

Filed Under: Featured, Gynecological, Legal News, Product Liability, Women's Health Tagged With: BD, becton dickinson, C.R. Bard, pelvic mesh

DTW Podcast: Vizient on PPE, Vicarious on VR-aided robotics and let’s all hope for pumpernickel

August 14, 2020 By Tom Salemi

This week’s episode of DeviceTalks Weekly is brought to you by the later V, as in Vizient and Vicarious Surgical. Bharat Sundaram, COO and president of Vizient, will share how the healthcare supplier is strengthening the supply of PPE for hospitals. He’ll also reveal when the company expects to see US hospitals running at pre-COVID […]

Filed Under: Device Talks Podcasts, Featured, Hospital Care, Robotics Tagged With: C.R. Bard, CooperVision, Medtronic, Neurolief, Theranos, Vicarious Surgical, vizient

Federal appeals court rejects preemption argument from BD’s Bard

August 14, 2020 By Chris Newmarker

The 9th U.S. Circuit Court of Appeals has handed down an important medical device preemption opinion as it affirmed a $3.6 million award against Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard in a bellwether lawsuit case over inferior vena cava filters. Bard’s lawyers had argued that when FDA reclassified intravascular filters as Class II devices, the […]

Filed Under: Cardiovascular, Featured, Legal News, Product Liability Tagged With: BD, becton dickinson, C.R. Bard, Preemption

Report: Ethylene oxide levels high near Georgia medtech sterilization plants

July 23, 2019 By Nancy Crotti

This article has been updated to include comments from Sterigenics. Medical device sterilization plants in the Atlanta area have come under scrutiny from neighbors and state officials following the publication of an investigative report by Georgia Health News and WebMD. Ethylene oxide plants owned by Sterigenics in Atlanta and Becton Dickinson in Covington, Ga., reported […]

Filed Under: Blog, Business/Financial News, Featured, News Well, Sterilization / Calibration Tagged With: C.R. Bard, sterigenics

BD’s Bard pulls all pelvic mesh products from EU market

March 7, 2019 By Fink Densford

Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard is removing its women’s pelvic organ prolapse and stress urinary incontinence mesh devices from the European Market, according to a recently posted field corrective action from the company. The Murray Hill, N.J.-based company said that it is “initiating a cease in production and distribution of these devices and a […]

Filed Under: Business/Financial News, Featured, Women's Health Tagged With: becton dickinson, C.R. Bard

Bard wins surgical mesh case on appeal

January 28, 2019 By Nancy Crotti

C.R. Bard (NYSE:BCR) and subsidiary Davol have won their appeal in a lawsuit involving a woman who died a year after having a Bard surgical mesh patch implanted to repair a hernia. The three-judge panel of the U.S. Court of Appeals for the Southern District of Indiana (Seventh Circuit) found that the estate of Georgia […]

Filed Under: Business/Financial News, Implants, Legal News, News Well Tagged With: C.R. Bard

QT Vascular expands pivotal trial of Chocolate Touch DCB

January 16, 2019 By Sarah Faulkner

QT Vascular said today that the FDA approved the company’s request to expand an on-going pivotal study of its Chocolate Touch drug-coated balloon to include the use of atherectomy for lesion preparation. The U.S. regulatory agency also approved the addition of subgroup analysis related to the use of atherectomy. Get the full story at our sister […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceutical, Regulatory/Compliance, Vascular Tagged With: C.R. Bard, QT Vascular

BD’s Bard updates on higher restenosis rate for LifeStream covered iliac stent

October 16, 2018 By Nancy Crotti

C.R. Bard (NYSE:BCR) has notified buyers of its LifeStream covered iliac stent of a higher-than-anticipated restenosis rate among patients. The field notice issued by Bard, parent company BD and Irish catheter-maker ClearStream Technologies said the restenosis rate of 0.04% exceeds the acceptable failure rate of 0.01%. An unspecified number of restenosis complaints was reported following implantation of […]

Filed Under: Featured, Stents, Vascular Tagged With: BD, C.R. Bard, Clearstream Technologies

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 30
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS